Skip to main content
logo
Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
100.72
+0.15 (0.15%)
At close: Oct 31, 2025, 4:00 PM EDT
100.82
+0.10 (0.10%)
After-hours: Oct 31, 2025, 7:59 PM EDT

Boston Scientific Revenue

Boston Scientific had revenue of $5.07B in the quarter ending September 30, 2025, with 20.34% growth. This brings the company's revenue in the last twelve months to $19.35B, up 21.61% year-over-year. In the year 2024, Boston Scientific had annual revenue of $16.75B with 17.61% growth.

Revenue (ttm)
$19.35B
Revenue Growth
+21.61%
P/S Ratio
7.69
Revenue / Employee
$365,075
Employees
53,000
Market Cap
149.24B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202416.75B2.51B17.61%
Dec 31, 202314.24B1.56B12.29%
Dec 31, 202212.68B794.00M6.68%
Dec 31, 202111.89B1.98B19.92%
Dec 31, 20209.91B-822.00M-7.66%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG56.37B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

BSX News

More News